Oct 13, 2026 04:01PM
Aug 12, 2026 04:01PM
Jun 23, 2026 08:05AM
Jun 8, 2026 08:06AM
May 26, 2026 11:44AM
May 14, 2026 04:03PM
Apr 29, 2026 08:05AM Sangamo Therapeutics moves to OTCQB after Nasdaq delisting notice
Mar 30, 2026 04:52PM
Feb 3, 2026 04:07PM
Feb 3, 2026 09:11AM
Feb 3, 2026 08:59AM
Dec 18, 2025 08:05AM
Nov 21, 2025 08:05AM
Nov 7, 2025 03:51AM Barclays Downgrades Sangamo BioSciences (SGMO) to Equalweight
Sep 5, 2025 06:47AM
Sep 4, 2025 08:05AM
Aug 7, 2025 04:07PM
Jun 25, 2025 06:43AM
Jun 24, 2025 08:05AM
May 29, 2025 07:04AM
May 13, 2025 06:56AM Sangamo BioSciences (SGMO) PT Lowered to $1.50 at Jefferies
May 6, 2025 08:31AM
Apr 8, 2025 06:44AM
Apr 3, 2025 04:01PM
Mar 19, 2025 09:15AM
Mar 18, 2025 04:49AM
Mar 17, 2025 04:05PM
Feb 6, 2025 08:06AM Sangamo Therapeutics (SGMO) Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile
Jan 23, 2025 11:56AM
Jan 2, 2025 06:37AM
Dec 31, 2024 06:41AM
Dec 31, 2024 05:43AM
Dec 30, 2024 04:17PM
Dec 13, 2024 06:07AM
Nov 19, 2024 04:15PM Sangamo Therapeutics (SGMO) Announces FDA Clearance of IND Application for ST-503
Nov 12, 2024 04:02PM
Nov 5, 2024 06:43AM
Oct 23, 2024 07:58AM
Oct 22, 2024 08:05AM
Aug 6, 2024 04:40PM
Aug 6, 2024 08:07AM
Jul 24, 2024 06:57AM Sangamo Therapeutics (SGMO) Reports on Pfizer’s (PFE) Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia A Gene Therapy Candidate

471,065 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All